The Antitrust Division of the U.S. Department of Justice has intensified its scrutiny of health care markets by establishing a dedicated task force: the Task Force on Health Care Monopolies and Collusion.
The risks go beyond a suit for an injunction. The Antitrust Division has been coordinating with False Claims Act prosecutors who have sought